Literature DB >> 36095316

Effectiveness of a Fourth Dose of COVID-19 mRNA Vaccine Against Omicron Variant Among Elderly People in Singapore.

Celine Y Tan1, Calvin J Chiew2, Vernon J Lee3, Benjamin Ong4, David Chien Lye5, Kelvin Bryan Tan3.   

Abstract

Entities:  

Year:  2022        PMID： 36095316      PMCID： PMC9578545          DOI： 10.7326/M22-2042

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   51.598


× No keyword cloud information.
  6 in total

1.  Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study.

Authors:  Sivan Gazit; Yaki Saciuk; Galit Perez; Asaf Peretz; Virginia E Pitzer; Tal Patalon
Journal:  BMJ       Date:  2022-05-24

2.  BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.

Authors:  Noa Dagan; Noam Barda; Eldad Kepten; Oren Miron; Shay Perchik; Mark A Katz; Miguel A Hernán; Marc Lipsitch; Ben Reis; Ran D Balicer
Journal:  N Engl J Med       Date:  2021-02-24       Impact factor: 91.245

3.  COVID-19 Vaccination Effectiveness Against Infection or Death in a National U.S. Health Care System : A Target Trial Emulation Study.

Authors:  George N Ioannou; Emily R Locke; Ann M O'Hare; Amy S B Bohnert; Edward J Boyko; Denise M Hynes; Kristin Berry
Journal:  Ann Intern Med       Date:  2021-12-21       Impact factor: 51.598

4.  Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.

Authors:  Nick Andrews; Julia Stowe; Freja Kirsebom; Samuel Toffa; Tim Rickeard; Eileen Gallagher; Charlotte Gower; Meaghan Kall; Natalie Groves; Anne-Marie O'Connell; David Simons; Paula B Blomquist; Asad Zaidi; Sophie Nash; Nurin Iwani Binti Abdul Aziz; Simon Thelwall; Gavin Dabrera; Richard Myers; Gayatri Amirthalingam; Saheer Gharbia; Jeffrey C Barrett; Richard Elson; Shamez N Ladhani; Neil Ferguson; Maria Zambon; Colin N J Campbell; Kevin Brown; Susan Hopkins; Meera Chand; Mary Ramsay; Jamie Lopez Bernal
Journal:  N Engl J Med       Date:  2022-03-02       Impact factor: 91.245

5.  Protection by a Fourth Dose of BNT162b2 against Omicron in Israel.

Authors:  Yinon M Bar-On; Yair Goldberg; Micha Mandel; Omri Bodenheimer; Ofra Amir; Laurence Freedman; Sharon Alroy-Preis; Nachman Ash; Amit Huppert; Ron Milo
Journal:  N Engl J Med       Date:  2022-04-05       Impact factor: 91.245

6.  Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.

Authors:  Ori Magen; Jacob G Waxman; Maya Makov-Assif; Roni Vered; Dror Dicker; Miguel A Hernán; Marc Lipsitch; Ben Y Reis; Ran D Balicer; Noa Dagan
Journal:  N Engl J Med       Date:  2022-04-13       Impact factor: 176.079
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.